Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma.
Kim TM, Taszner M, Novelli S, Cho SG, Villasboas JC, Merli M, Jiménez-Ubieto A, Tessoulin B, Poon LM, Tucker D, Walewski J, Yi S, Song Y, Chong G, Bachy E, Guidez S, Alonso A, Jagadeesh D, Zhang W, Magnano L, Iskierka-Jażdżewska E, Tani M, Shen B, Uppala A, Zhu M, Shariff S, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Luminari S; ELM-2 Investigators. Kim TM, et al. Among authors: alonso a. Ann Oncol. 2024 Nov;35(11):1039-1047. doi: 10.1016/j.annonc.2024.08.2239. Epub 2024 Aug 13. Ann Oncol. 2024. PMID: 39147364 Free article. Clinical Trial.
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047].
Kim TM, Taszner M, Novelli S, Cho SG, Villasboas JC, Merli M, Jiménez-Ubieto A, Tessoulin B, Poon LM, Tucker D, Walewski J, Yi S, Song Y, Chong G, Bachy E, Guidez S, Alonso A, Jagadeesh D, Zhang W, Magnano L, Iskierka-Jażdżwska E, Tani M, Shen B, Uppala A, Zhu M, Shariff S, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Luminari S; ELM-2 Investigators. Kim TM, et al. Among authors: alonso a. Ann Oncol. 2024 Dec 2:S0923-7534(24)04945-7. doi: 10.1016/j.annonc.2024.11.009. Online ahead of print. Ann Oncol. 2024. PMID: 39627085 Free article. No abstract available.
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP).
Alegre A, Benzo G, Alonso R, Martínez-López J, Jimenez-Ubieto A, Cuéllar C, Askari E, Prieto E, Aláez C, Aguado B, Velasco A, Krsnik I, Bocanegra A, Llorente L, Muñoz-Linares C, Morales A, Giménez E, Iglesias R, Martínez-Chamorro C, Alonso A, Jiménez-Montes C, Blanchard MJ; Grupo GM-GM. Alegre A, et al. Among authors: alonso a, alonso r. Oncol Ther. 2023 Mar;11(1):83-96. doi: 10.1007/s40487-022-00212-5. Epub 2022 Dec 12. Oncol Ther. 2023. PMID: 36509945 Free PMC article.
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.
Suvannasankha A, Bahlis N, Trudel S, Weisel K, Koenecke C, Oriol A, Voorhees PM, Alonso AA, Callander NS, Mateos MV, Reddy N, Hakim S, LaMacchia J, Patel N, Williams D, Jewell RC, Zhou X, Gupta I, Opalinska J, Nooka AK. Suvannasankha A, et al. Among authors: alonso aa. Cancer. 2024 Aug 1;130(15):2629-2641. doi: 10.1002/cncr.35319. Epub 2024 Apr 17. Cancer. 2024. PMID: 38630908 Clinical Trial.
Machine Learning Algorithms in Controlled Donation After Circulatory Death Under Normothermic Regional Perfusion: A Graft Survival Prediction Model.
Calleja R, Rivera M, Guijo-Rubio D, Hessheimer AJ, de la Rosa G, Gastaca M, Otero A, Ramírez P, Boscà-Robledo A, Santoyo J, Marín Gómez LM, Villar Del Moral J, Fundora Y, Lladó L, Loinaz C, Jiménez-Garrido MC, Rodríguez-Laíz G, López-Baena JÁ, Charco R, Varo E, Rotellar F, Alonso A, Rodríguez-Sanjuan JC, Blanco G, Nuño J, Pacheco D, Coll E, Domínguez-Gil B, Fondevila C, Ayllón MD, Durán M, Ciria R, Gutiérrez PA, Gómez-Orellana A, Hervás-Martínez C, Briceño J. Calleja R, et al. Among authors: alonso a. Transplantation. 2025 Jan 9. doi: 10.1097/TP.0000000000005312. Online ahead of print. Transplantation. 2025. PMID: 39780307
The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC).
Li D, An B, Men L, Glittenberg M, Lutsey PL, Mielke MM, Yu F, Hoogeveen RC, Gottesman R, Zhang L, Meyer M, Sullivan K, Zantek N, Alonso A, Walker KA. Li D, et al. Among authors: alonso a. J Alzheimers Dis. 2025 Jan 8:13872877241305806. doi: 10.1177/13872877241305806. Online ahead of print. J Alzheimers Dis. 2025. PMID: 39772982
Exploring Cognitive and Neuroimaging Profiles of Dementia Subtypes of Individuals with Dementia in the Democratic Republic of Congo.
Ikanga J, Patel SS, Schwinne M, Obenauf C, Epenge E, Gikelekele G, Tshengele N, Kavugho I, Mampunza S, Mananga L, Teunissen CE, Rojas JC, Chan B, Lario Lago A, Kramer JH, Boxer AL, Jeromin A, Omba E, Alonso A, Gross AL. Ikanga J, et al. Among authors: alonso a. medRxiv [Preprint]. 2024 Dec 18:2024.12.17.24319162. doi: 10.1101/2024.12.17.24319162. medRxiv. 2024. PMID: 39763528 Free PMC article. Preprint.
Birth weight and head circumference for 22-29 weeks gestation neonates from an international cohort.
Fenton TR, Alshaikh B, Kusuda S, Helenius K, Modi N, Norman M, Lui K, Lehtonen L, Battin M, Klinger G, Vento M, Lastrucci V, Gagliardi L, Adams M, Marba STM, Isayama T, Hakansson S, Bassler D, Shah PS; International Network for Evaluation of Outcomes (iNeo) of Neonates Investigators. Fenton TR, et al. Arch Dis Child Fetal Neonatal Ed. 2025 Jan 6:fetalneonatal-2024-327845. doi: 10.1136/archdischild-2024-327845. Online ahead of print. Arch Dis Child Fetal Neonatal Ed. 2025. PMID: 39762001
3,434 results